EP3261721 - Bibliographic data
UTILISATION DE PRIDOPIDINE POUR AMÉLIORER LA MÉMOIRE
| Last update | 13/05/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
Prilenia Neurotherapeutics Ltd. 10 HaMenofim Street
Herzliya 4672561
Israël
The Board of Regents of The University of Texas System 201 West 7th Street
Austin, TX 78701
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Michal GEVA Rozmarin 5
P.O.Box 7253
Even-Yehuda
Israël
Ilya BEZPROZVANNY Dallas, TX 75205
États-Unis d'Amérique
Merav BASSAN Ramat Gan 5253179
Israël
Michael HAYDEN Herzliya 4672561
Israël
|
| (74) Agent |
Mail recipient
COSMOVICI PAUL 11 boulevard Sébastopol
75001
PARIS
France
|
| (21) Request number | EP16756274.3 |
|---|---|
| (22) Request date | 24/02/2016 |
| (11) Publication number | EP3261721 |
|---|---|
| Publication date | 14/09/2022 |
| (54) Title of the invention | UTILISATION DE PRIDOPIDINE POUR AMÉLIORER LA MÉMOIRE |
|---|---|
| (51) International classification | A61K 31/451, C07D 211/24, A61P 25/28 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201562120771 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity | Annuity: 11 - Amount: 240 € - Due date 02/03/2026 |
|---|---|
| Last annuity | Annuity: 10 - Payment date 28/01/2025 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 14/09/2022 Constitution de mandataire pour un dossier - Legal date 30/11/2022 |